相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis
Soren Moller et al.
LIVER INTERNATIONAL (2018)
The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats
Philipp Schwabl et al.
SCIENTIFIC REPORTS (2018)
Rhynchophylla total alkaloid rescues autophagy, decreases oxidative stress and improves endothelial vasodilation in spontaneous hypertensive rats
Chao Li et al.
ACTA PHARMACOLOGICA SINICA (2018)
Aicar treatment reduces interstitial fibrosis in aging mice Suppression of the inflammatory fibroblast
Katarzyna A. Cieslik et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
Pathological process of liver sinusoidal endothelial cells in liver diseases
Yao Ni et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy
Bogdan Procopet et al.
GASTROENTEROLOGY REPORT (2017)
Advances and challenges in cirrhosis and portal hypertension
Annalisa Berzigotti
BMC MEDICINE (2017)
The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis
Daniel Karin et al.
DIFFERENTIATION (2016)
Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis
Juan G. Abraldes et al.
GASTROENTEROLOGY (2016)
Clinical implications of basic research in hepatocellular carcinoma
Renumathy Dhanasekaran et al.
JOURNAL OF HEPATOLOGY (2016)
Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy
Mihajlo Gjeorgjievski et al.
WORLD JOURNAL OF HEPATOLOGY (2016)
Melatonin protects hepatocytes against bile acid-induced mitochondrial oxidative stress via the AMPK-SIRT3-SOD2 pathway
Y. Chen et al.
FREE RADICAL RESEARCH (2015)
Molecular Pathophysiology of Portal Hypertension
Mercedes Fernandez
HEPATOLOGY (2015)
5-Aminoimidazole-4-carboxamide-1β-D-ribofuranoside alleviated carbon tetrachloride-induced acute hepatitis in mice
Changming Yang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Suppression of oxidative stress and improvement of liver functions in mice by ursolic acid via LKB1-AMP-activated protein kinase signaling
Yongbin Yang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments
Jaume Bosch et al.
JOURNAL OF HEPATOLOGY (2015)
Pharmacological activation of AMPK prevents Drp1-mediated mitochondrial fission and alleviates endoplasmic reticulum stress-associated endothelial dysfunction
Jia Li et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Nitric oxide in liver diseases
Yasuko Iwakiri et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Nitric oxide stress and activation of AMP-activated protein kinase impair β-cell sarcoendoplasmic reticulum calcium ATPase 2b activity and protein stability
X. Tong et al.
CELL DEATH & DISEASE (2015)
KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins
Giusi Marrone et al.
GUT (2015)
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis
Ali A. Mokdad et al.
BMC MEDICINE (2014)
Obeticholic Acid, a Farnesoid X Receptor Agonist, Improves Portal Hypertension by Two Distinct Pathways in Cirrhotic Rats
Len Verbeke et al.
HEPATOLOGY (2014)
Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice
Xia Cao et al.
HYPERTENSION RESEARCH (2014)
The AMPK Agonist AICAR Inhibits TGF-β1 Induced Activation of Kidney Myofibroblasts
Kuan-Hsing Chen et al.
PLOS ONE (2014)
Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol
Thomas Reiberger et al.
GUT (2013)
Current concepts on the role of nitric oxide in portal hypertension
Liang Shuo Hu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Nitric oxide: considerations for the treatment of ischemic stroke
Nicole A. Terpolilli et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects
Sabine Klein et al.
JOURNAL OF HEPATOLOGY (2012)
AMP-Activated Protein Kinase Inhibits Homocysteine-Induced Dysfunction and Apoptosis in Endothelial Progenitor Cells
Fang Jia et al.
CARDIOVASCULAR DRUGS AND THERAPY (2011)
Novel Engineered Targeted Interferon-gamma Blocks Hepatic Fibrogenesis in Mice
Ruchi Bansal et al.
HEPATOLOGY (2011)
Reduction of Fibrogenesis by Selective Delivery of a Rho Kinase Inhibitor to Hepatic Stellate Cells in Mice
M. M. van Beuge et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Increased Liver Uptake and Reduced Hepatic Stellate Cell Activation with a Cell-Specific Conjugate of the Rho-kinase Inhibitor Y27632
Marike Marjolijn van Beuge et al.
PHARMACEUTICAL RESEARCH (2011)
NCX 1000 Alone or in Combination with Vitamin E Reverses Experimental Nonalcoholic Steatohepatitis in the Rat Similarly to UDCA
Yara Haddad et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2011)
Activation of AMP-Activated Protein Kinase by 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside in the Muscle Microcirculation Increases Nitric Oxide Synthesis and Microvascular Perfusion
Eloise A. Bradley et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Ghrelin Attenuates Hepatocellular Injury and Liver Fibrogenesis in Rodents and Influences Fibrosis Progression in Humans
Montserrat Moreno et al.
HEPATOLOGY (2010)
Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats
Leonor Rivera et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
Juan G. Abraldes et al.
GASTROENTEROLOGY (2009)
Randomized Controlled Trial of Carvedilol Versus Variceal Band Ligation for the Prevention of the First Variceal Bleed
Dhiraj Tripathi et al.
HEPATOLOGY (2009)
Possible mechanisms involved in the discrepancy of hepatic and aortic endothelial nitric oxide synthases during the development of cirrhosis in rats
Morvarid Shir Mohammadi et al.
LIVER INTERNATIONAL (2009)
High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase
Masayuki Adachi et al.
HEPATOLOGY (2008)
Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension
Erwin Biecker et al.
LIVER INTERNATIONAL (2008)
Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase
Jonel Trebicka et al.
HEPATOLOGY (2007)
Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats
Juan G. Abraldes et al.
JOURNAL OF HEPATOLOGY (2007)
Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders
Benoit Viollet et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis
C Zafra et al.
GASTROENTEROLOGY (2004)
Intracerebroventricular metformin attenuates salt-induced hypertension in spontaneously hypertensive rats
JS Petersen et al.
AMERICAN JOURNAL OF HYPERTENSION (2001)
Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction
M Oelze et al.
CIRCULATION RESEARCH (2000)
分享论文
